research article

oai:eprints.ucl.ac.uk.OAI2:1502534

Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?

Authors: AJ Furness
SA Quezada
KS Peggs
Publication date: 1 June 2016
Publisher: 'Future Medicine Ltd'
Doi

Abstract

Abstract is not available.

Article
Science & Technology, Life Sciences & Biomedicine, Immunology, CTLA-4, Heterogeneity, Neoantigens, PD-1, Tumor-Infiltrating Lymphocytes, Cytolytic T-Lymphocytes, Metastatic Melanoma, CTLA-4 Blockade, Untreated Melanoma, HLA-A2 Melanomas, Lung-Cancer, Ipilimumab, Antigen, Nivolumab

Similar works

Full text

thumbnail-image

Open in the Core reader

UCL Discovery

oai:eprints.ucl.ac.uk.OAI2:150...

Last time updated on 10/03/2017

This paper was published in UCL Discovery.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.